Univest
Univest
  • Markets

CreditAccess Grameen Share: Pros and Cons Every Investor Must Know in 2026

  • August 10, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments

CreditAccess Grameen share CMP approx Rs 1,528. 52-week high Rs 1,634, low Rs 1,113. Market Cap Rs 28,600 Cr. P/E ratio 17.86x.

Quick Answer

  • CreditAccess Grameen share — Q1 FY27 profit Rs 493 Cr (up 719% YoY) confirms MFI sector earnings trough passed
  • India’s best-managed MFI with Dutch parent CreditAccess India BV providing international governance
  • Current CMP Rs 1,528 — below 52-week high Rs 1,634, suggesting full recovery premium not yet priced in

Is the CreditAccess Grameen share a good investment in 2026? This article provides a data-driven analysis of CreditAccess Grameen share pros and cons — covering business strengths, valuation, growth drivers, and key risks — based on live data from 7 August 2026.

Click Here — Get Free Investment Predictions

Table of Contents

Toggle
  • About CreditAccess Grameen
  • Key Financial Snapshot: CreditAccess Grameen Share
  • Top 5 Pros of CreditAccess Grameen Share
    • 1. Q1 FY27 Profit 719 Percent YoY Recovery — Sector Earnings Trough Is Confirmed Passed
    • 2. International Dutch Parent Governance — Best-in-Class MFI Risk Management
    • 3. 16 States Geographic Diversification — Not Single-State Concentration Risk
    • 4. Rising Ticket Size — Individual Secured Loans Beyond Group Microfinance
    • 5. 52-Week Range Shows Recovery Premium Not Fully Priced — Rs 1,113 to Rs 1,634
  • Key Cons of CreditAccess Grameen Share
    • 1. Sector-Wide Borrower Overleveraging Remains Unresolved — Multiple MFI Loans per Borrower
    • 2. Karnataka and Maharashtra Concentration — Southern India Sensitivity
    • 3. Group Loan NPA Inherently More Volatile Than Secured Retail NPA
    • 4. 17.86x PE — Requires Continued Earnings Recovery to Sustain
  • Is CreditAccess Grameen Share a Good Investment in 2026?
  • Key Risks Before Buying CreditAccess Grameen Share
  • Conclusion
  • Frequently Asked Questions — CreditAccess Grameen Share
    • What are the main pros of CreditAccess Grameen share?
    • What are the risks?
    • Is CreditAccess Grameen share a good investment?
    • What is the 52-week range?
    • How does CreditAccess Grameen differ from Ujjivan SFB and Bandhan Bank?
    • What happened during the 2024-25 MFI crisis?

About CreditAccess Grameen

CreditAccess Grameen Limited (NSE: CREDITACC) is a Bengaluru-based microfinance institution founded in 1999 with Dutch parent CreditAccess India BV. It provides micro group loans to low-income rural women across 16 states through 1,967 branches. India’s best-managed MFI, it is consistently rated highest for risk management and governance among listed MFI companies.

Key Financial Snapshot: CreditAccess Grameen Share

Parameter Details
Company CreditAccess Grameen
NSE Symbol CREDITACC
Sector Microfinance NBFC
CMP (Approx) Rs 1,528
52-Week High Rs 1,634
52-Week Low Rs 1,113
Market Cap Rs 28,600 Cr
P/E Ratio 17.86x

Data approximate. Verify at nseindia.com.

Top 5 Pros of CreditAccess Grameen Share

1. Q1 FY27 Profit 719 Percent YoY Recovery — Sector Earnings Trough Is Confirmed Passed

The Q1 FY27 profit recovery from Rs 59 crore to Rs 493 crore — a 719 percent YoY jump — is the most compelling evidence that CreditAccess Grameen’s MFI sector earnings trough is behind it. This recovery trajectory makes 17.86x PE moderate and potentially cheap on forward normalised earnings.

2. International Dutch Parent Governance — Best-in-Class MFI Risk Management

CreditAccess India BV brings global microfinance expertise and institutional risk management standards that purely Indian-owned MFIs lack. This quality differentiates CreditAccess Grameen even through sector-wide credit stress cycles.

3. 16 States Geographic Diversification — Not Single-State Concentration Risk

With 1,967 branches across 16 states, CreditAccess Grameen has structural geographic diversification that limits the impact of any single state’s credit cycle — unlike smaller MFIs concentrated in 1 to 3 states.

4. Rising Ticket Size — Individual Secured Loans Beyond Group Microfinance

CreditAccess Grameen is growing secured individual loans for borrowers who have graduated from group microfinance — adding vehicle and home loans that carry lower write-off rates than unsecured group lending.

5. 52-Week Range Shows Recovery Premium Not Fully Priced — Rs 1,113 to Rs 1,634

CreditAccess Grameen recovered from MFI stress lows of Rs 1,113 to Rs 1,528 current. The 52-week high of Rs 1,634 has not been reclaimed — suggesting full earnings recovery premium is not yet priced in at current levels.

Key Cons of CreditAccess Grameen Share

1. Sector-Wide Borrower Overleveraging Remains Unresolved — Multiple MFI Loans per Borrower

Despite individual company quality, the sector-wide problem of rural women borrowers simultaneously holding 4 to 6 concurrent MFI loans is an unresolved structural issue that could create another NPA cycle if not addressed through industry regulation.

2. Karnataka and Maharashtra Concentration — Southern India Sensitivity

Despite 16-state presence, CreditAccess Grameen’s loan book is heavily weighted in Karnataka and Maharashtra — the states most severely impacted by the 2024-25 MFI crisis — creating geographic earnings concentration.

3. Group Loan NPA Inherently More Volatile Than Secured Retail NPA

Micro group loans can deteriorate sharply when economic shocks (drought, job loss) affect entire joint liability groups simultaneously. This NPA volatility is structurally different from and greater than secured retail lending.

4. 17.86x PE — Requires Continued Earnings Recovery to Sustain

At 17.86x PE, CreditAccess Grameen share requires continued earnings recovery from Q1 FY27 levels toward normalised ROE of 15 to 18 percent. Any re-elevation of MFI credit costs would make this PE expensive quickly.

Use the Univest Screener to Analyse Stocks for Free

Is CreditAccess Grameen Share a Good Investment in 2026?

CreditAccess Grameen share is India’s highest-quality MFI with sector trough confirmed passed. The 17.86x PE is reasonable on forward normalised earnings. Consider as quality MFI recovery core allocation.

Key Risks Before Buying CreditAccess Grameen Share

  • Sector-wide MFI borrower overleveraging worsening triggering another NPA cycle
  • Karnataka or Maharashtra economic stress creating concentrated book NPA
  • Dutch parent reducing stake reducing international governance credibility
  • RBI imposing MFI borrower indebtedness caps reducing industry loan sizes

Conclusion

The CreditAccess Grameen share offers q1 fy27 profit 719 percent yoy recovery — sector earnings trough is confirmed passed as its primary investment case. Weigh it against sector-wide borrower overleveraging remains unresolved — multiple mfi loans per borrower and the risks above before investing. Use the Univest Screener and consult a SEBI-registered advisor.

Download the Univest iOS App or Univest Android App to track CreditAccess Grameen share price live.

Disclaimer: Data from publicly available sources. Approximate as of 7 Aug 2026. Verify on nseindia.com and bseindia.com. Not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions — CreditAccess Grameen Share

What are the main pros of CreditAccess Grameen share?

Ans. Q1 FY27 profit 719% YoY confirming MFI sector earnings trough passed, international Dutch parent governance as India’s best-managed MFI, 16-state geographic diversification limiting single-state risk, rising ticket size secured lending improving portfolio quality, and 52-week high Rs 1,634 not yet reclaimed suggesting further recovery room.

What are the risks?

Ans. Sector-wide borrower overleveraging remaining unresolved for another NPA cycle, Karnataka and Maharashtra geographic concentration, inherent group loan NPA volatility versus secured retail, and 17.86x PE requiring continued earnings recovery. Monitor monthly MFI credit data and RBI regulatory updates.

Is CreditAccess Grameen share a good investment?

Ans. India’s highest-quality MFI at moderate PE with earnings recovery underway. Consider as MFI sector recovery core allocation. Consult a SEBI-registered advisor. Not investment advice.

What is the 52-week range?

Ans. 52-week high Rs 1,634, low Rs 1,113. Current Rs 1,528. Verify at nseindia.com.

How does CreditAccess Grameen differ from Ujjivan SFB and Bandhan Bank?

Ans. CreditAccess Grameen is a pure-play NBFC-MFI (no banking licence, cannot take retail deposits). Ujjivan and Bandhan are SFBs that can accept deposits, reducing funding costs. CreditAccess compensates with superior risk management and international parent governance. For best quality MFI pure-play, CreditAccess Grameen is preferred.

What happened during the 2024-25 MFI crisis?

Ans. Rural borrower overleveraging — where borrowers simultaneously held 4 to 6 MFI loans each — created debt traps and group default spirals. CreditAccess Grameen’s Q1 FY26 profit fell to Rs 59 crore. By Q1 FY27, disciplined credit management enabled recovery to Rs 493 crore — faster than peers including Ujjivan, Jana SFB, and Spandana Sphoorty.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply